Monsanto has greater fall than expected profit and sales

                

The American expert on genetically modified organisms (GMOs) Monsanto, the target of a takeover offer worth 62 billion dollars by its German rival Bayer announced Wednesday an unexpected drop in its profit and sales in the third quarter lagged the year 2016.

In this period, which ended in late May, net profit fell 37%, to 717 million, while its turnover dropped 8.5%, to 4.2 billion.

On Wall Street, the stock fell more than 1% in electronic trading prior to opening, before the disappointment of brokers who expected sales of around 4,490 billion dollars.